Related Experiment Video
Updated: Aug 7, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity
Koichiro Yasuda1, Tetsuro Matsunaga, Tetsuya Adachi
1Laboratory of Metabolism, Graduate School of Human and Environmental Studies, Kyoto University, Kyoto, and Diabetic Center, Tsunashimakai-Kosei Hospital, Himeji, Japan. yasuda2@tom.life.h.kyoto-u.ac.jp
Adrenergic receptor (AR) gene variations are linked to obesity and autonomic nervous system (ANS) function. This review explores how AR polymorphisms impact metabolism and obesity, offering insights into related diseases.
Area of Science:
- Endocrinology
- Metabolic Physiology
- Genetics
Background:
- Adrenergic receptors (ARs) are crucial for the autonomic nervous system (ANS), regulating energy homeostasis and metabolism.
- Dysfunctional ANS metabolism is linked to obesity and metabolic diseases.
- ARs are G-protein-coupled receptors for catecholamines.
Purpose of the Study:
- To review the current understanding of adrenergic receptor (AR) polymorphisms.
- To examine the association between AR polymorphisms and human obesity.
- To explore the link between AR function, obesity, and ANS activity.
Main Methods:
- Literature review of in vitro and human clinical studies.
- Analysis of existing research on AR polymorphisms and obesity phenotypes.
- Synthesis of data on the functional and pathophysiological significance of AR variations.
Main Results:
- Several studies suggest a connection between specific AR polymorphisms and obesity.
- Some AR polymorphisms demonstrate functional significance impacting ANS function.
- Evidence indicates a role for AR alterations in the pathophysiology of metabolic diseases.
Conclusions:
- AR polymorphisms are potentially implicated in the development of obesity and related metabolic disorders.
- Understanding AR genetic variations offers insights into ANS dysfunction in obesity.
- Further research into ARs may reveal therapeutic targets for metabolic diseases.
More Related Videos
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
10:40Characterization of Adipocyte-Derived Extracellular Vesicle Secretion Using a CD63-GFP Reporter Mouse Model In Vivo and In Vitro
Published on: December 5, 2025
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Adrenergic Neurons: Neurotransmission
Synthesis: Catecholamine synthesis requires tyrosine, which is taken...